Vetnews | Julie 2025 22 « BACK TO CONTENTS Article This represents a promising direction in chytridiomycosis research because parasite variability has been implicated in driving disease outcomes in hosts. Similar analyses of Plasmodium spp. suggest mechanisms of immune evasion in mosquito vectors (Molina-Cruz et al. 2015) and have identified loci associated with antimalarial drug resistance under positive selection (Shen et al. 2017). Genetic tools have also located hotspots of polygenomic malaria infection, where hosts harbour multiple parasite strains simultaneously (Rice et al. 2016). Considered together, this information enables better monitoring of where malaria transmission and polygenomic infection rates are high and suggests possible molecular mechanisms for disease control. To pursue these research and management goals, genetic analyses have been conducted on a wide range of parasite taxa (Supporting Information). Going forward, it is critical to focus on additional pathogens in multi-host systems occurring in geographically diverse populations, particularly where spillover is likely. Further, it is important to perform comparative analyses in the contexts of host phenotype, genotype, and environment (Lazzaro & Little 2009). Host Genetics Studies of host genetics tend to focus on resistance, tolerance, and diversity. Resistance can be defined as the ability to eliminate parasites from the host, whereas tolerance imposes limits on the parasite’s negative effects (Best et al. 2008, 2009; R˚aberg et al. 2009). Host fitness is intimately coupled with these traits and forms a significant component of their underlying mechanistic and molecular processes. In both cases, the prevailing paradigm is based on the assumption that genetic diversity at immune loci buffers hosts from disease risk. As such, demography resulting in genomic diversity loss (e.g., inbreeding) is often associated with increased likelihood of disease-mediated population decline (Spielman et al. 2004). Early researchers examining host genetics in wildlife disease adopted a broad definition of genetic diversity. Employing neutral microsatellite markers, they calculated summary statistics to determine whether host genetics correlated with disease state. Although many reported significant relationships (Coltman et al. 1999), others failed to identify strong associations between neutral diversity and disease (Schwensow et al. 2007). This led many to question the efficacy of using neutral markers as a proxy for genome-wide variation (V¨ali et al. 2008) and ultimately shifted the field toward a more targeted immunogenetic approach. In vertebrate systems, the major histocompatibility complex (MHC) dominated the literature. Critical to adaptive immunity, this hypervariable gene family encodes for MHC molecules that bind to antigens and display them on cell surfaces to initiate an immune response. This renders MHC variation a convenient target for candidate gene approaches. For example, analyses of Tasmanian devils threatened by DFTD suggest that low MHC diversity in hosts may provide means of immune evasion for this transmissible cancer (Siddle et al. 2007). Similar analyses in amphibians show associations between MHC diversity and survival in frogs experimentally infected with the pathogenic fungus Batrachochytrium dendrobatidis (Bd) and host species known to be Bd resistant (Fu & Waldman 2017). The MHC-based explorations of host disease state consider only one aspect of immunity, however. Many other genes (e.g., Tolllike receptors) also aid host defence (Acevedo-Whitehouse & Cunningham 2006). Further, specific genes often associate with disease state more strongly than summary statistics of genetic variation (Bateson et al. 2016); thus, treating MHC diversity as a proxy for larger-scale immunogenetic variation may eventually prove too reductionist. Genomic methods are increasingly used by conservation scientists to pursue more comprehensive analyses. Since publication of the first human genome, technological advances have rendered whole genome sequencing accessible for wildlife studies. Even when whole genomes are unavailable, restriction enzyme-based methods rapidly and affordably generate genome-wide data (Davey & Blaxter 2010). For example, genomic analyses confirmed low levels of standing variation in Tasmanian devils, identified geographic structuring of host populations, enabled reconstruction of DFTD emergence and transmission pathways, and supported allograft transmission of this contagious cancer (Murchison et al. 2012; Grueber et al. 2015; Morris et al. 2015; Hendricks et al. 2017). Although in accordance with earlier MHC-based studies, genomic analyses enabled deeper understanding of the roles host and cancer genomics play in DFTD pathogenesis. They additionally positioned genetic diversity maintenance as a top conservation priority for wild and captive devil management. We hope that more systems will benefit from similarly comprehensive analyses. Although the trend toward genome-level data comes with inherent difficulties, it provides critical insight into complex disease dynamics. By integrating the study of parasite and host genomics, wildlife managers can leverage better understanding of parasite virulence, transmission, and host disease state toward more effective prevention and management. Host Gene Regulation in Immunity For the immune system to properly function, genes must produce their corresponding antigen binding, recognition, and signaling proteins. Gene regulatory variation therefore arises as another contributor to host disease state. If an underlying genotype for host immunity is transcriptionally silenced, infection becomes likely. For example, suppression of inflammatory response genes in bats may allow them to asymptomatically harbor viruses that are highly damaging to nonvolant mammals (Brook & Dobson 2015; Banerjee et al. 2017). Epigenetic mechanisms (e.g., DNA methylation, histone modification, etc.) can alter the expression of immune genes in response to environmental stimuli, thereby inducing or preventing an immune response (Morandini et al. 2016). Thus, effective immunity requires action from both genetic and epigenetic dimensions of the host genome: the genetic capacity to recognize and respond to a diverse array of parasites, the concerted expression of those genes, and the ability to overcome immune escape efforts. The functional link between epigenetics and immunity is a burgeoning field. Although many studies focus on tumour growth, autoimmune disorders, and developmental changes, increasing attention is being paid to epigenetic mechanisms operating in infectious disease (Pacis et al. 2014; Zhao et al. 2015). From the perspective of resistant hosts, fine-tuned regulation of immune genes and tissues targeted by pathogens may enable early detection and eradication of infecting parasites, as seen in some frogs experimentally infected with Bd (Ellison et al. 2014).
RkJQdWJsaXNoZXIy OTc5MDU=